ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

STX Shield Therapeutics Plc

2.00
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.00 1.95 2.05 2.00 2.00 2.00 294 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.38 15.51M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.95p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £15.51 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.38.

Shield Therapeutics Share Discussion Threads

Showing 5726 to 5747 of 23125 messages
Chat Pages: Latest  241  240  239  238  237  236  235  234  233  232  231  230  Older
DateSubjectAuthorDiscuss
01/5/2020
06:50
one smudge in of advice when reading research notes from brokers look at the accounts to see how much they are getting paid by the repressive Company it may have a bearing on what is been wrote
best1467
01/5/2020
06:47
Of course iv requires a visit to a hospital for a vulnerable person. So assuming this crisis lasts for a quite a while, the advantage of an oral therapy is clear!
nobbygnome
01/5/2020
06:40
In these times a pretty good update
Money to Norgine is fair enough..lets see what comes from the review. As it states still positives that are not in question in the review that can be used moving forward.

Positive re US deals..... "significant interest from a range of companies" and "talks have advanced in recent weeks". So hopefully not far away now.

Norgine sales have seen growth

Supplies ok and thus "will be able to supply US promptly"......very promising line

China still moving forward during this period of lockdown...massive market

Paediatric study slight delay..fair enough.Great potential there.

Plenty of cash in hand into 2021

Great line in CEO statement "confident of the pressing need for our product as an IV alternative"


IV alternative for the worlds biggest deficiency, and a pressing need. US market is massive and they have the supplies to move straight into the US. Looking forward to that update.

peachie 74
01/5/2020
06:29
The reality is all that matters from a share price point of view ultimately is the US deal. Because of the precipitate decline there is plenty of upside if they get a half decent deal. It's an open goal really, although not sure what will happen today. If there is a sell off because of the repayment of the milestone, then it will be a good buying opportunity.
nobbygnome
01/5/2020
06:23
yesterday’s rise probably due to this...

“we have been able to advance discussions with interested parties in recent weeks“

ny boy
01/5/2020
06:18
Trading seems good, no disruption to supply. Money back to Norgine that was expected.
montyhedge
01/5/2020
06:15
Yes good and bad in the update. Ultimately they still have cash into the first quarter of next year so under no real time pressure for the US negotiations. It sounds like progress has been made with those negotiations and I think the current lockdown helps. Other companies I am involved in have said that it is easier to speak to the required people at present which facilitates deal making.
nobbygnome
01/5/2020
06:06
Trading update released. They agreed to repay Norgine the money for the H2H milestone. Not much else.
crankyman
01/5/2020
00:35
Bought into this yesterday ( not on a large scale) but intrigued by the product. Happy as anything to see a 21% rise in one day. Nice to see anything going green at the moment!
decolady1
30/4/2020
19:54
But it has been his thing for a long time.

I think he would be against a takeover at this stage. Who knows !?

peachie 74
30/4/2020
19:06
I'm sure he would not be against a takeover if he holds 10% even at today's price. In presentations he always said that his aim was to make sure the small investors were looked after/did well as they normally get screwed over. Perhaps the big shareholders didn't like that mentality...
ekcs
30/4/2020
15:13
Let’s see after the bell, if there is any broker news or press, could be investorS just switched into this for safety and the sp, had simply got too cheap and was not valuing anything for FDA broad label approval, last summer?
ny boy
30/4/2020
14:48
Not convinced he was/is against a take over. Everyone has a price. I’m sure he would not mind pocketing 30-50 million quid.
crankyman
30/4/2020
14:33
Nobby I did mention that a takeover could possibly be the only positive from the recent departure of CS aS founder of the company He may have been totally against it .That could be behind the recent rise who knows but while depending on price I would imagine we would not get the long term true value if a takeover is about to happen
My guess would be around the £2.00/£2.50 level where as with the right USA partner deal and everything going to plan in China in 2/3 years we could be closer to the £4/5 level even higher if the trial with P20 I think it is goes well

best1467
30/4/2020
14:05
It's a risk off day, so this is a good performance. If it was a risk on day, perhaps this would have been back to 150p.
montyhedge
30/4/2020
13:36
It’s possible some people who used to hold have decided to return
crankyman
30/4/2020
12:14
Of course taking a breather but this is a strong move on a down day for the market. Must be something going on, no rns yet.
montyhedge
30/4/2020
11:47
Above for anyone thinking of investing. Great read

And another below

peachie 74
30/4/2020
11:24
Good progress, await with great interest news of a US commercialisation deal or takeover

Happy to hold GLA

ny boy
30/4/2020
11:19
157 million MK is peanuts for a company with a product to revolutionise a multi billion dollar industry worldwide.

Something has got to be around the corner

peachie 74
30/4/2020
11:16
He does retain his holding. 9% if I remember

About 50% of these are in “safe hands” I think

peachie 74
30/4/2020
11:04
Latest resistance Levels

Resistance1: 159.00p Resistance2: 185.71p

ny boy
Chat Pages: Latest  241  240  239  238  237  236  235  234  233  232  231  230  Older

Your Recent History

Delayed Upgrade Clock